<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11-vaccines-08-00306">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gregg</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Harberts</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Gardner</surname>
    <given-names>F.M.</given-names>
   </name>
   <name>
    <surname>Pelletier</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Cayatte</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>McCarthy</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Marshall</surname>
    <given-names>J.D.</given-names>
   </name>
   <name>
    <surname>Ernst</surname>
    <given-names>R.K.</given-names>
   </name>
  </person-group>
  <article-title>Rationally designed tlr4 ligands for vaccine adjuvant discovery</article-title>
  <source>MBio</source>
  <year>2017</year>
  <volume>8</volume>
  <fpage>e00492-17</fpage>
  <pub-id pub-id-type="doi">10.1128/mBio.00492-17</pub-id>
  <?supplied-pmid 28487429?>
  <pub-id pub-id-type="pmid">28487429</pub-id>
 </element-citation>
</ref>
